Response to: 'Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future' by Wang et al

Janine A Lamb¹, Spyridon Megremis², Hector Chinoy^{3

4}

Affiliations

¹ Division of Population Health, Health Services Research and Primary Care, The University of Manchester, Manchester, UK janine.lamb@manchester.ac.uk.
² Division of Evolution and Genomic Sciences, The University of Manchester, Manchester, UK.
³ National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, The University of Manchester, Manchester, UK.
⁴ Department of Rheumatology, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK.

PMID: 32759262
DOI: 10.1136/annrheumdis-2020-218712

Comment

Response to: 'Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future' by Wang et al

Janine A Lamb et al. Ann Rheum Dis. 2022 Oct.

. 2022 Oct;81(10):e193.

doi: 10.1136/annrheumdis-2020-218712. Epub 2020 Aug 5.

Authors

Janine A Lamb¹, Spyridon Megremis², Hector Chinoy^{3

4}

Affiliations

¹ Division of Population Health, Health Services Research and Primary Care, The University of Manchester, Manchester, UK janine.lamb@manchester.ac.uk.
² Division of Evolution and Genomic Sciences, The University of Manchester, Manchester, UK.
³ National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, The University of Manchester, Manchester, UK.
⁴ Department of Rheumatology, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK.

PMID: 32759262
DOI: 10.1136/annrheumdis-2020-218712

No abstract available

Keywords: autoantibodies; autoimmune diseases; dermatomyositis; pulmonary fibrosis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.
Megremis S, Walker TDJ, He X, Ollier WER, Chinoy H, Hampson L, Hampson I, Lamb JA. Megremis S, et al. Ann Rheum Dis. 2020 Oct;79(10):1383-1386. doi: 10.1136/annrheumdis-2020-217522. Epub 2020 May 22. Ann Rheum Dis. 2020. PMID: 32444414 Free PMC article. No abstract available.
Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future.
Wang Y, Du G, Zhang G, Matucci-Cerinic M, Furst DE. Wang Y, et al. Ann Rheum Dis. 2022 Oct;81(10):e192. doi: 10.1136/annrheumdis-2020-218594. Epub 2020 Aug 5. Ann Rheum Dis. 2022. PMID: 32759260 No abstract available.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

MR/N003322/1/MRC_/Medical Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to: 'Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future' by Wang et al

Affiliations

Response to: 'Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future' by Wang et al

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical